Evidence map›Paper›PMID 24755313›Full record

Trial reportCancer prevention research (Philadelphia, Pa.)2014

Short- and long-term lung cancer risk associated with noncalcified nodules observed on low-dose CT.

Paul F Pinsky, P Hrudaya Nath, David S Gierada, Sushil Sonavane, Eva Szabo

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer prevention research (Philadelphia, Pa.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.Cancer prevention research (Philadelphia, Pa.) · 2016
    Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  10. Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Article
  11. Long-term effects of inhaled budesonide on screening-detected lung nodules.Annals of oncology : official journal of the European Society for Medical Oncology · 2015
    Article
  12. Review
  13. Review
  14. Indeterminate pulmonary nodules: risk for having or for developing lung cancer?Cancer prevention research (Philadelphia, Pa.) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Paul F PinskyDivision of Cancer Prevention, NCI, NIH, Bethesda, Maryland. pp4f@nih.gov.
P Hrudaya NathUniversity of Alabama at Birmingham, Birmingham, Alabama.
David S GieradaWashington University School of Medicine, St. Louis, Missouri.
Sushil SonavaneUniversity of Alabama at Birmingham, Birmingham, Alabama.
Eva SzaboDivision of Cancer Prevention, NCI, NIH, Bethesda, Maryland.
University of Alabama at Birmingham · USWashington University in St. Louis · US

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

Chemoprevention is an important potential tool in reducing lung cancer incidence. Noncalcified nodules (NCN) observed on low-dose computed tomography (LDCT) have been proposed as intermediate endpoints in chemoprevention trials, but whether NCNs represent cancer precursors is unclear. We analyzed data from subjects in the LDCT arm of the National Lung Screening Trial (NLST) to examine short- and long-term lung cancer risks associated with NCNs and to elucidate whether some NCNs may be cancer precursors. NLST subjects received a baseline and two additional LDCT screens and were followed for a median of 6.5 years. We examined lung cancer incidence over three distinct periods from baseline-0-23 months (short-term), 24-59 months (medium-term), and 60-84 months (long-term)-in relation to baseline NCN characteristics. Spatially, lung cancer incidence was analyzed at the person, lung, and lobe levels relative to NCN location. A total of 26,272 subjects received the baseline LDCT screen, with 468, 413, and 190 lung cancers observed in the three periods. The presence of an NCN gave significantly elevated long-term lung cancer risk ratios (RR) of 1.8, 2.4, and 3.5 at the person, lung, and lobe levels; corresponding short-term RRs were 10.3, 16.8, and 38.0. Ground-glass attenuation was positively associated with long-term lung cancer risk but inversely associated with short-term risk; NCN size was positively associated with short-term risk but not significantly associated with long-term risk. That NCNs convey significantly elevated excess long-term of lung cancer lends evidence to the hypothesis that some NCNs may be cancer precursors.

Indexed as

Early Detection of CancerAgedAlabamaCohort StudiesFemaleFollow-Up StudiesHumansIncidenceLung NeoplasmsMaleMiddle AgedMultiple Pulmonary NodulesNeoplasm StagingPrognosisRisk FactorsSmoking

Identifiers

PMID24755313
PMCPMC4206664
OpenAlexW2067323212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.